The Hedgehog (Hh) and Wingless (Wnt) families of secreted signaling molecules have key roles in embryonic development and adult tissue homeostasis [1] [2] [3] . In the developing neural tube, Wnt and Shh, emanating from dorsal and ventral regions, respectively, have been proposed to govern the proliferation and survival of neural progenitors [4] [5] [6] [7] [8] [9] [10] . Surprisingly, Shh is required for the growth and survival of cells in both ventral and dorsal neural tube [11] . Here we demonstrate that inhibition of Shh signaling causes a reduction in Wnt-mediated transcriptional activation. This reduction requires Gli3. Assays in embryos and cell lines indicate that repressor forms of the Hh-regulated transcription factor, Gli3 (Gli3R), which are generated in the absence of Hh signaling, inhibit canonical Wnt signaling. Gli3R acts by antagonizing active forms of the Wnt transcriptional effector, b-catenin. Consistent with this, Gli3R appears to physically interact with the carboxy-terminal domain of b-catenin, a region that includes the transactivation domain. These data offer an explanation for the proliferative defects in Shh null embryos and suggest a novel mechanism for crosstalk between the Hh and Wnt pathways.
Results and Discussion
Repressor Forms of Gli3 Inhibit Canonical Wnt Signaling Shh signaling regulates the growth and survival of progenitors in the neural tube [11] . In the absence of Shh, an overall reduction in the size of the neural tube was evident ( Figure 1A) . Surprisingly, this reduction in neural tube growth did not appear to be confined to ventral progenitors because mitotic cells were distributed evenly along the dorsoventral axis. Moreover, apoptotic figures were located in both dorsal and ventral regions of the neural tube ( Figure 1A and data not shown). Because Wnt signaling, derived from dorsal aspects of the neural tube, has been suggested to regulate dorsal progenitors, we analyzed the expression of the Wntresponsive gene Axin2 [4, 12] . Strikingly, compared to littermate controls, Axin2 expression was reduced in Shh null embryos ( Figure 1A ), suggesting that Wnt signaling is decreased in the absence of Shh signaling.
To analyze this further, we directly measured canonical Wnt signaling activity by using reporter assays in embryonic chick neural tubes ( Figures 1B-1D ). First, we used a reporter consisting of the Axin2 promoter [12] . Transfection of Wnt3a increased by 2-to 3-fold the Axin2 reporter activity. To test whether inhibiting Hh signaling influenced the Wnt response of neural cells, we used Ptc1
Dloop2 , a dominant active form of the Hh receptor, Ptc1, which inhibits Hh signaling cell autonomously at the receptor level [13] . In embryos cotransfected with Wnt3a and Ptc1
Dloop2
, the ability of Wnt3a to induce the Axin2 reporter activity was greatly reduced ( Figure 1C ).
To confirm an inhibitory effect of Ptc1
Dloop2 on Wnt signaling, we performed similar assays with the wellestablished TCF-luciferase reporter plasmid, pTOP-FLASH. In this reporter, six optimized TCF binding sites control the expression of luciferase [14] . Transfection of a Wnt3a expression plasmid increased pTOPFLASH activity 10-to 20-fold in neural cells ( Figure 1D ). Cotransfection with Ptc1
Dloop2 reduced significantly the pTOP-FLASH activity induced by Wnt3a. Together, these results suggest that blockade of Shh signaling decreases the responsiveness of neural cells to canonical Wnt signaling.
The absence of the proliferation defects in Shh
Gli3
xt/xt mutants [8] prompted us to examine Axin2 expression in these embryos. Axin2 expression was similar in Shh 2/2 ;Gli3 xt/xt mutants to wild-type litter-mates (Figure 1E) , indicating that the reduction of Wnt signaling observed in the absence of Shh signaling is dependent on Gli3. In the absence of Shh signaling, Gli3 is proteolytically processed to a transcriptional repressor form, termed Gli3R [15] [16] [17] [18] [19] [20] . We therefore tested whether a construct encoding Gli3R inhibited Wnt signaling. Coelectroporation of Gli3R decreased the ability of Wnt3a to induce pTOPFLASH activity ( Figure 1F ), indicating that repressor forms of Gli3 inhibit canonical Wnt signaling in neural cells. This suggests that endogenous forms of Gli3R mediate the inhibition of Wnt signaling caused by Ptc1
Dloop2 . Consistent with this, coelectroporation of a dominant-negative form of PKA, which inhibits formation of Gli3R [19] , rescues the inhibitory effects of Ptc1
Dloop2 on Wnt signaling (see Figure S1 in the Supplemental Data available online). We did not detect marked differences in Axin2 expression between Gli3 xt/xt mutants and their wild-type littermates (data not shown). This is consistent with the absence of proliferation defects in the neural tube of Gli3-deficient mice [20] and suggests that the levels of Gli3R necessary to affect Wnt signaling are only achieved in the Shh 2/2 background. This implies that sufficient Shh signaling normally reaches the dorsal neural tube to reduce Gli3R below a level at which Wnt signaling is inhibited. Together, the data suggest a model in which increased levels of Gli3R formed in Shh-deficient mice are able to inhibit Wnt signaling. This model explains the presence of defects in the dorsal neural tube of Shh null embryos despite the proproliferative activity of Wnt signaling. Figure 1G ). Cells were transfected with reporter plasmids either alone, with Gli3R, or with Gli1, a Gli protein that acts solely as a transcriptional activator [16, 17] . In each cell line, Wnt3a-induced activity was markedly reduced by cotransfection with Gli3R ( Figure 1G ). In contrast, the level of pTOPFLASH activity was not significantly affected in cells transfected with Gli1 in the presence or absence of Wnt3a treatment ( Figure 1G ), supporting the idea that pTOPFLASH does not respond directly to Gli activity. In addition, the activity of a reporter consisting of mutated TCF binding sites, unable to interact with TCF (pFOPFLASH), was unaffected in the same experimental conditions ( Figure 1G ).
To rule out the possibility that the effects of Gli3R were nonspecific, we tested the ability of TNF to induce NfkB/ Rel activity. TNF treatment of HEK293 cells induced an 8-fold increase in NfkB/Rel activity, and transfection of (C and D) HH stage 11-12 chick embryos were coelectroporated with a reporter consisting of the firefly luciferase under the control of the Axin 2 promoter (0.3 mg/ml) (C) or pTOPFLASH (0.3 mg/ml) (D), a normalization plasmid consisting of a renilla luciferase under the control of a CMV promoter (0.05 mg/ml) and either empty pCAGGS vector, Wnt3a (1 mg/ml), or Wnt3a and Ptc1
Dloop2 (2 mg/ml). Total amount of DNA was adjusted to 3.35 mg/ml by appropriate empty vectors. The levels of firefly and renilla luciferase were measured 24 hr after the electroporation. Ptc1 Dloop2 , which inhibits Shh pathway, decreased the response of neural cells to Wnt3a. (E) Axin2 in situ hybridization performed on transverse sections at the thoracic level of wild-type and Shh 2/2 ;Gli3 xt/xt E9.5 mice embryos. Loss of Gli3 rescues the reduction of Axin2 expression observed in the spinal cord of Shh 2/2 mutants (A). (F) In ovo luciferase assay performed as described in (C) and (D) and with pTOPFLASH as a reporter and a construct encoding the repressor form of Gli3 (Gli3R) (2 mg/ml). Gli3R was sufficient to decrease the response of neural cells to Wnt3a. (G) Luciferase assay in cultured cells. HEK293, HT-1080, and COS-7 cells were transfected with pTOPFLASH (250 ng), CMV renilla luciferase normalization plasmid (10 ng), and Gli1, Gli3R, or empty pCAGGS (50 ng). Cells were cultured in the absence or presence of Wnt3a conditioned media and luciferase activities measured 24 hr after transfection. The activity of a reporter containing mutated TCF binding sites (pFOPFLASH) was also assayed in HEK293 cells. Forced expression of Gli3R inhibited the response to Wnt3a in each of the cell lines tested. (H) TNF signaling assay in HEK293 cells. Cells were transfected with an NFkB firefly luciferase reporter construct (100 ng), CMV renilla luciferase normalization plasmid (10 ng), and Gli3R (20 ng) or pCAGGS empty vector. After 24 hr, cells were transferred to 0.5% serum media supplemented as indicated with TNF (40 ng/ml). After overnight incubation, the luciferase activities were measured. The response to TNF was unaffected by Gli3R. Error bars indicate standard deviation.
Gli3R did not affect the activity of TNF ( Figure 1H ). Together, these data suggest that Gli3R selectively inhibits canonical Wnt signaling in a range of cell types.
Gli3R Inhibits b-Catenin Activity
To ascertain at which step of the Wnt pathway (Figure 2A) Gli3R exerted its effects, we activated the Wnt signaling at different levels and tested the ability of Gli3R to inhibit the response ( Figure 2B ). Wnt signaling, activated by transfection of Wnt3a, LRP6, and Dishevelled and by LiCl-mediated inhibition of GSK-3b, was blocked by cotransfection of Gli3R. Moreover, Gli3R inhibited the activity of a dominant active, stabilized form of b-catenin lacking the first 87 amino acids (b-catenin Act ) [21] and a version of b-catenin lacking the GSK3b phosphorylation site necessary for its rapid degradation (data not shown) [22] . Forced expression of Gli1 did not affect the activity of stabilized b-catenin, while a construct encoding full-length Gli3, which is partially processed in vivo, moderately reduced its activity (data not shown). Consistent with the capacity of Gli3R to affect the Wnt pathway by modulating b-catenin activity, Gli3R expression inhibited pTOPFLASH activity in a panel of colon cancer cells containing mutations that stabilize endogenous b-catenin ( Figure S2) .
The results suggested that Gli3R exerts its action on the Wnt pathway at or downstream of b-catenin. To determine whether Gli3R inhibited TCF/Lef expression or the interaction of TCF/Lef with b-catenin, we analyzed the effect of Gli3R on the activity of constitutively active b-catenin fusion constructs. The Wnt-independent induction of pTOPFLASH activity by a fusion of the Lef1 HMG-box domain to the b-catenin transactivation domain (Lef1-b-catenin; diagrams describing the structure of the constructs used in this work are indicated below) [23] was inhibited by cotransfection of Gli3R ( Figure 2C ).
In contrast, Gli3R had only minor inhibitory effect on the ability of a Lef1-Vp16 fusion protein ( Figure 2D ) [23] . These data indicate that Gli3R does not mediate its effects by repressing Tcf/Lef expression, inhibiting Tcf/Lef DNA-binding ability, or blocking an interaction between Tcf/Lef and b-catenin. Instead, the data favor the idea that Gli3R inhibits Wnt signaling by inhibiting the activity of b-catenin.
To confirm the inhibitory effect of Gli3R on b-catenin activity, in vivo, we examined whether Gli3R abrogated the ability of b-catenin to induce secondary axes in Xenopus leavis embryos [24] . Injection of dominant active b-catenin RNA (b-catenin Act ) into a ventral-vegetal blastomere of a 8-cell stage Xenopus embryo induced the formation of secondary axes in w50% of embryos ( Figure 3 ). This effect was blocked by coinjection of a dominant-negative form of Tcf-3 (DN-Tcf3) [25] . In a similar manner, coinjection of Gli3R also blocked secondary axis-inducing activity of b-catenin (Figure 3 ). These data are consistent with those obtained in the luciferase assays and indicate that Gli3R is able to inhibit activated b-catenin signaling in vitro and in vivo in a broad range of different cell types.
Evidence for an Interaction between Gli3R and b-Catenin
How does Gli3R inhibit b-catenin activity? Two properties that regulate b-catenin activity are its stability and subcellular location [2] ; however, Gli3R did not produce observable changes in the subcellular distribution of either transfected b-catenin protein or endogenous b-catenin, and the stability of b-catenin was not decreased by Gli3R ( Figure S3 ). Moreover, Gli3R expression did not significantly inhibit the expression of the b-catenin cofactors CBP, p300, Brg1, Bcl9, or Pygopus ( Figure S3 ). We therefore considered whether Gli3R physically interacted with b-catenin. To examine this, we first performed coimmunoprecipitation experiments in HEK293 cells ( Figures 4A and 4B ). Cells were transfected, either alone or in combination, with b-catenin Act and Myctagged Gli3R. b-catenin complexes were immunoprecipitated with an anti-b-catenin antisera that recognizes endogenous and transfected b-catenin. In cells transfected with Gli3R, anti-b-catenin was able to immunoprecipitate Gli3R ( Figure 4B ). To discriminate between Gli3R interaction with Lef/TCF proteins or b-catenin, we performed immunoprecipitation experiments in cells cotransfected with Myc-Gli3R and HA-Lef-1-b-catenin or HA-Lef1-Vp16. Immunoprecipitation of Myc-Gli3R revealed that HA-Lef1-b-catenin, but not HA-Lef1-Vp16, complexed with Gli3R ( Figure 4B ). These data suggest that Gli3R and b-catenin proteins may be present in the same complex; moreover, the C-terminal transactivation domain of b-catenin appears sufficient to mediate the formation of this complex because the Lef-1-b-catenin fusion protein contains only this region of b-catenin.
We next examined the ability of b-catenin to interact with Gli3R in vitro ( Figure 4C ). We found that, compared to GST-alone controls, Gli3R (Gli3 1-645) was enriched in complexes containing GST-b-catenin [26] . Consistent with the coimmunoprecipitation data, Gli3R was able to interact with the last 200 amino acids of b-catenin (GST-b-catenin CT), a region that includes the C-terminal transactivation domain. In contrast, Gli3R interacted only poorly with b-catenin lacking this region (GST-b-catenin-D-CT). To determine the region of Gli3R that interacts with b-catenin, we performed the same assays with several truncated versions of Gli3 ( Figure 4C ). These data suggest that regions of Gli3R amino terminal to amino acid 395 are able to interact with b-catenin. Together, the data support the idea that Gli3R and b-catenin can form a complex and raise the possibility of a direct physical interaction between b-catenin and Gli3R ( Figure 4C) .
These data suggest a model in which a physical interaction between Gli3R and b-catenin inhibits the transcriptional activity of b-catenin. The correlation between the ability of Gli3R to interact with variants of b-catenin and the capacity to inhibit the transactivation supports this idea: thus, Gli3R inhibits and coprecipitates with b-catenin Act and Lef1-b-catenin but not Lef1-Vp16. Suppressor of fused (SUFU) has previously been shown to coimmunoprecipitate with both Gli proteins and b-catenin and to inhibit b-catenin [27, 28] . Together with our data, this raises the possibility that a complex between b-catenin, Gli3R, and SUFU inhibits b-catenin activity, perhaps by displacing b-catenin coactivators or by recruiting corepressors. Whether SUFU is required for the formation or function of a Gli-b-catenin complex remains to be determined.
This study provides evidence that, in the absence of Shh signaling, high levels of Gli3R act to inhibit Wnt signaling. This explains why, in Shh-deficient mice, proliferation and survival defects are present along the entire dorsoventral axis of the neural tube and why these defects are rescued in Shh 2/2 ;Gli3 xt/xt mice. Crosstalk is also evident in nonneural cells. These data therefore raise the possibility that interactions between Shh and Wnt signaling also influence some of the biological functions of the two signaling pathways in other tissues.
Experimental Procedures
Mice Embryos were generated from Shh +/2 [29] and Gli3 +/Xt [30] mice.
Cells and Plasmids
All cell lines were cultured in standard conditions. TNFa was obtained from Sigma. Transfections were carried out with the Lipofectamine-Plus Reagent (Invitrogen). When required, transfected cells were purified by GFP fluorescence by FACS. Gli3R consists of aa 1-645 of human Gli3 fused to either 6X Myc or Flag tag at the N terminus expressed from either pCAGGS-IRES-nlsGFP [31] or pCS2 [32] . Both constructs show similar repressor properties in cells and chick embryos (data not shown). Mouse Wnt3a (from A. McMahon), human LRP6 (from X. He), Xenopus Dsh (from S. Sokol), and Lef1-b-catenin and LEF1-Vp16 (from A. Hecht) were all in pCS2.
Immunofluorescence and In Situ Hybridization
Inmunofluorescence detection of apoptotic cells was performed with a rabbit antibody detecting the activated form of caspase 3 (Cell Signaling). Secondary antibodies were from Jackson. Images were collected on a Zeiss Axioplan 2 fluorescence microscope. In situ hybridization of Axin2 was performed as described [12] .
Luciferase Assay
Luciferase measurements were performed with the Dual-Luciferase Reporter Assay System (Promega). Axin2 promoter luciferase reporter was obtained from F. Costantini [12] . TOPFLASH and FOPFLASH reporters were obtained from Upstate Biotechnology. NfkB reporter plasmid was obtained from Clontech. CMV-renilla luciferase was obtained from Promega. Luciferase assays in embryonic chick neural tubes have been described previously [33] .
Xenopus Secondary Axis Assay Capped RNA was synthesized and injected into the marginal zone of one of ventral-vegetal blastomeres in 8-cell stage Xenopus embryos. The amount injected was: b-catenin 200 pg; LacZ, Gli3R, DN-Tcf3 250 pg. The embryos were incubated until stage 40 and categorized into three groups; 2 axes (with an ectopic axis with eyes and cement gland), 1 axis + 1 partial axis (with a clear secondary axis without any eye structure), and 1 axis.
Coimmunoprecipitation
Transfected HEK293 cells were lysed with lysis buffer (50 mM TrisHCl [pH 7.5], 1% Triton X-100, 0.05% SDS, and 0.2% BSA) containing Halt protease inhibitor cocktail (Pierce). Protein extracts were incubated overnight at 4 C with 1 ml of rabbit anti-b-catenin antibody (Sigma) and protein A sepharose (Pharmacia) or 1 ml of mAb antiMyc antibody 9B11 (Cell Signaling) and protein G sepharose (Pharmacia) or 4 ml of rat Ab anti-HA antibody 3F10 (Roche) and protein G sepharose. Then the beads were washed 4 times with 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, and 0.05% SDS and two times with PBS. The material immunoprecipitated was fractioned by SDS-PAGE, transferred to a nitrocellulose membrane, and detected by immunoblot with the mAb 9E10 (Santa Cruz) to detect the myc epitope of Gli3R, or the Ab 3F10 to detect the HA epitope.
In Vitro Protein Binding Assays GST-b-catenin full length was kindly provided by R. Kemler [26] . This construct was used to generate forms that lack (GST-b-catenin-D-CT) or contain only (GST-b-catenin CT) the last 200 amino acids of b-catenin sequence. Recombinant GST proteins were expressed in E. coli and purified with Glutathione Sepharose beads. Gli3R was produced with the TNT in vitro transcription/translation system (Promega) according to the manufacturer's instructions. 10 ml of translation reactions were incubated with GST or GST-b-catenin in 150 mM KCl, 20 mM HEPES (pH 7.9), 0.1% NP40, 5 mM MgCl 2 , 0.2% BSA, and the Halt protein inhibitors cocktail (Pierce) during 5 hr at 4 C. The beads were washed four times in 150 mM KCl, 20 mM HEPES (pH 7.9), 0.1% NP-40, 5 mM MgCl 2 , and protease inhibitors, and the bound proteins were resolved on SDS-PAGE and revealed by autoradiography. Figure S4 ). Note that lane order has been rearranged for clarity and the images of coimmunoprecipitation shown correspond to longer exposure times than the images of the western blots of total lysates (original gel images are available as supplemental data; see Figure S4 ). Total lysates are 1/10 of the material used for the coprecipitation reactions. (C) In vitro interaction assay. GST-b-catenin full-length, GST-b-catenin-D-CT, GST-b-catenin-CT, or GST alone were incubated with in vitro translated fragments of Gli3 labeled with 35 S Met. GST proteins were captured with Glutathione-Sepharose beads, then proteins were fractioned by SDS-PAGE before autoradiography. The coomassie blue staining of GST proteins employed is shown. Input are 1/10 of the material used for the in vitro interaction reactions. Results of the interaction assays are summarized diagrammatically. N-terminal regions of Gli3 interact in vitro with the C-terminal region of b-catenin.
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